A deletion within chromosome 22q11 has been identified in the majority of patients with DiGeorge syndrome, velocardiofacial syndrome, conotruncal anomaly face syndrome and in some cases of Cayler cardiofacial syndrome and Opitz G/BBB syndrome (1, 2) . Phenotypic features associated with a chromosome 22q11 deletion are highly variable and include cardiovascular anomalies, palatal abnormalities, hypocalcemia, thymic hypoplasia/aplasia, immune dysfunction, renal abnormalities, characteristic facial features, motor developmental delay and speech and learning disabilities (1, 2) .
Over the past several years, numerous studies have shown that a deletion within chromosome 22q11 is associated with certain forms of congenital cardiovascular disease, including tetralogy of Fallot with and without pulmonary atresia, truncus arteriosus and interruption of the aortic arch (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . In a recent prospective investigation, we characterized the frequency of chromosome 22q11 deletions in an unselected series of 251 patients with a broad range of anomalies of the cardiac outflow tracts and aortic arch (3) . We found that a 22q11 deletion was significantly more common in patients with abnormal branching or laterality of the aortic arch than it was in those with a left-sided arch and normal branching of the brachiocephalic vessels, regardless of the primary cardiovascular defect. Multiple logistic regression analysis showed that both right-sidedness (abnormal laterality) of the arch and aberrant branching of arteries derived from the pharyngeal arches (including the proximal PAs) were independently associated with an increased frequency of chromosomal deletion. Of note, approximately two-thirds of the 45 patients with a chromosome 22q11 deletion in that series had anomalies of the aortic arch or proximal PAs associated with their cardiac defect. The association between anomalies of the pharyngeal arch derivatives and chromosomal deletion has been noted by other investigators as well (4, 5, 9, 12) . Based on these observations, we hypothesized that patients with aortic arch anomalies and normal intracardiac anatomy would have a high frequency of 22q11 deletion. To test this hypothesis, we studied 66 patients with an isolated anomaly of aortic arch laterality or branching for evidence of chromosome 22q11 deletion.
METHODS

Patients.
We approached a total of 76 patients known to have abnormalities of branching or laterality of the aortic arch without associated intracardiac defects or interrupted aortic arch. Patients with an arch anomaly and associated abnormalities of arteries derived from the pharyngeal arches, such as hypoplasia or atresia of a proximal branch pulmonary artery (PA), or obstruction of a cervical aortic arch were included as long as no other cardiac anomalies were present. Approximately half of the 76 patients were approached prospectively at the time of admission for repair of vascular rings. The others were contacted retrospectively after referral for evaluation or repair of aortic arch anomalies.
Of the 76 patients contacted, 66 (87%) agreed to participate and underwent evaluation in accordance with our study protocol, which was approved by the Institutional Review Board for the Protection of Human Subjects at the Children's Hospital of Philadelphia. Written informed consent was obtained from all subjects before enrollment. Parents of 10 patients contacted retrospectively declined to participate and cited the desire not to subject their child to additional venipuncture as their primary reason for declining. The diagnoses of these patients did not differ notably from the cohort of participants. It is important to add that the retrospective arm of our enrollment process was not colored by survival bias. During the period from which surgical patients were enrolled, there were no deaths among patients undergoing repair of an isolated vascular ring. Cardiovascular phenotype. There was a wide range of diagnoses among the 66 patients included in the study (Table 1) . In all patients, the diagnosis was confirmed by echocardiography (n ϭ 44), magnetic resonance imaging (n ϭ 54), computed tomography (n ϭ 2) and/or observation during surgery (n ϭ 47). Twenty-two patients with double aortic arch were enrolled, 18 with a dominant right arch and 4 with a dominant left arch. Nine subjects with a right aortic arch and mirror-image branching of the brachiocephalic vessels were studied, including five with a vascular ring formed by a left-sided ductus arteriosus from the descending aorta to the left PA (four with a left descending aorta and one with a right-sided descending aorta) and four with a right-sided or bilateral ductus and no vascular ring. There were 28 subjects with a vascular ring formed by a right aortic arch with an aberrant left subclavian artery (SCA) arising from a retroesophageal diverticulum and a left-sided ductus. The remaining seven patients had a left aortic arch with an aberrant right SCA and no vascular ring. Altogether, 55
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RESULTS
Deletions within chromosome 22q11 were identified in 16 of our 66 patients (24%). In particular, a 22q11 deletion was present in 14% of patients with a double aortic arch, 22% of patients with a right aortic arch and mirror-image branching of the brachiocephalic vessels, 32% of patients with a right aortic arch and aberrant left SCA and 29% of patients with a left aortic arch and aberrant right SCA. The frequencies of chromosomal deletion for each specific type of anomaly are summarized in Table 1 .
In the analysis of the entire cohort of 66 patients, there were no significant differences in the frequency of chromosomal deletion among the primary diagnostic categories ( Table 2 ). The only significant difference in frequency of chromosome 22q11 deletion was between patients with and without abnormalities of the proximal branch PAs, with a higher frequency of deletion in the former. Presence or absence of a double aortic arch, vascular ring, cervical aortic arch, coarctation of the aorta and airway compression did not correlate with chromosomal deletion. When patients with a double aortic arch were excluded from the analysis, arch laterality did not correlate with frequency of deletion. Among patients with a double aortic arch, those with an atretic minor arch had a significantly higher frequency of deletion than those with a patent minor arch, but there was no difference between patients with left and right dominance of the double arch (Table 2 ). There was no difference in age at diagnosis or surgery between patients with and without a 22q11 deletion in the entire study group (p ϭ 0.51) or in the cohort of patients who required surgical intervention (p ϭ 0.84).
In all 16 patients with a chromosome 22q11 deletion, comprehensive family histories and results of fluorescence in situ hybridization testing for 22q11 deletion in first-degree relatives were available. The only first-degree relative found to have a chromosome 22q11 deletion was the father of Patient 27. The patient had a right-dominant double aortic arch, while the father had a right aortic arch with mirrorimage branching of the brachiocephalic arteries and no vascular ring.
DISCUSSION
Chromosome 22q11 deletion and anomalies of the aortic arch. We have demonstrated a significant association between deletions of chromosome 22q11 and isolated anomalies of aortic arch laterality or branching. The overall frequency of 22q11 deletion in this cohort is similar to other lesions commonly associated with chromosome 22q11 deletion (3). The frequency of deletion was similar across the spectrum of arch anomalies that we studied, with no significant differences between the four primary diagnostic categories. Among the associated anatomic features that were examined, the frequency of deletion was higher in patients with atresia or significant stenosis of the proximal branch PAs than it was in those without. However, there were only six patients with such abnormalities in our cohort. Among patients with a double aortic arch, those with an atretic minor arch were more likely to have a deletion within chromosome 22q11 than were those with a patent minor arch. Again, sample size was small and, therefore, this finding must be interpreted with caution.
Numerous anomalies of the aortic arch system have been described (16,17), including many rare defects that are not represented in this study. Our study does not include several abnormalities of pharyngeal arch derivatives that have been reported in association with chromosome 22q11 deletion, such as isolation of a SCA and malposition of the branch PAs (otherwise known as crossed PAs) (5, 9) . Although malposition of the PAs is not an abnormality of the aortic arch and its branches, it most likely represents aberrant development of the proximal sixth pharyngeal arches, which are populated by cells from the cardiac neural crest in the same manner as the third and fourth pharyngeal arches (18) . Similarly, nonconfluent or stenotic PAs have been linked to chromosome 22q11 deletion in previous reports of patients with tetralogy of Fallot or truncus arteriosus (4, 12, 13) . Patients with the various arch anomalies not included in this study may also be at risk for a 22q11 deletion. Genotype/phenotype considerations. Substantial clinical heterogeneity has been observed with respect to the cardiovascular lesions associated with deletion of chromosome 22q11 (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . The cardiac phenotype ranges from complex intracardiac and aortic arch anomalies to completely normal anatomy. Even among the isolated anomalies of the aortic arch that are included in this study, 10 distinct patterns were found in patients with a 22q11 deletion. Based on the primitive system of pharyngeal arches proposed by Edwards (19) , each of the lesions in our series appears to result from a different process of aberrant vascular development (Fig. 1) . Deletion size does not correlate with phenotype (20) . Thus, the observed phenotypic variability associated with the 22q11 deletion remains to be explained. Both genetic background and in utero environmental exposures have been implicated. Animal models have been developed that may shed light on this issue (21) . Potential study limitations. This study was based largely on the ascertainment of patients with clinical signs or symptoms for which they underwent cardiopulmonary evaluation and, hence, may not reflect the true frequency of chromosome 22q11 deletion across the spectrum of isolated anomalies of aortic arch laterality or branching. For example, a right aortic arch with mirror-image branching and no associated cardiac anomalies is highly unusual (22) , and may come to clinical attention only sporadically, either because of incidental detection of the right arch on imaging of the chest for other reasons, or as in the case of our four patients (who had stenosis or atresia of the proximal left PA), because of associated conditions that warranted cardiac evaluation. Similarly, individuals with a left aortic arch and aberrant right SCA may not come to clinical attention, as demonstrated in a recent autopsy report of nearly 5,000 patients (4 to 86 years of age) without known cardiovascular defects, in which the incidence of occult left arch with aberrant right SCA was 1.6 per 1,000 patients (23) .
Clinical implications. These findings should alert the cardiologist that a chromosome 22q11 deletion occurs in a substantial number of patients with isolated aortic arch anomalies and normal intracardiac anatomy. Many patients with isolated arch anomalies present with symptoms as neonates or young infants. Screening for the deletion may be warranted in such patients, even in the absence of other overt features of the 22q11 deletion syndrome, since many of the typical features seen in the 22q11 deletion syndrome (1,2) may not be evident during infancy (24, 25) . In particular, facial features may not be apparent in infants, renal findings are not evident on routine examination, and the characteristic speech and learning difficulties typically do not become clear until beyond infancy. Features that help identify the infant at risk for chromosome 22q11 deletion include nasal regurgitation with feeding, thymic hypoplasia and hypocalcemia. Early diagnosis of a 22q11 deletion in infants with congenital cardiovascular disease allows for early detection of associated noncardiac features, as well as appropriate genetic counseling. In contrast, patients with isolated vascular anomalies who come to clinical attention at an older age are more likely to have evidence of other syndromic features if they have a chromosome 22q11 deletion, such that more selective chromosomal screening can be considered.
